The recombinant CLDN4 antibody was prepared by obtaining the antibody genes, cloning the genes into a plasma vector to construct vector clone, transfecting the vector clone into a mammalian cell line for transient expression, and purifying the antibody by affinity-chromatography. This recombinant CLDN4 antibody has been verified to detect the CLDN4 protein from Human in the ELISA.
CLDN4 is a transmembrane protein involved in tight junction formation and function. It is responsible for the maintenance of epithelial cell polarity and the establishment of the intercellular barrier. CLDN4 is a well-known differentiation marker, and its presence is regarded to indicate a more epithelial phenotype. Decreased expression of CLDN4 correlates with EMT. High expression of CLDN4 has been reported in multiple human malignancies, including ovarian, renal, and bladder cancer.
Email: support@cusabio.com
Distributors Worldwide